{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:13:02Z","timestamp":1795129982639,"version":"4.10.3"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Implantation is the rate-limiting step in the success of both intrauterine Insemination (IUI) and\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      fertilization cycles. Numerous interventions that target various local signals have been tried to improve the implantation and clinical pregnancy rate (CPR). The most significant of these signals is human chorionic gonadotropin (hCG) which acts as immunomodulator and improves implantation by decidualization of the endometrial stromal cells, trophoblast invasion, proliferation of uterine natural killer cells, stimulation of endometrial angiogenesis, and maintenance of progesterone secretion by the corpus luteum.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of the study is to evaluate the effect of intrauterine hCG administration before IUI on CPR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>A prospective parallel randomized control study was done from September 2017 to February 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 200 eligible women planned for IUI were randomly divided just before IUI into 2 groups. A computer-generated randomization list with block size of 10 with 1:1 allocation was used to randomize the patients. Experimental group received 0.5 ml containing 500 IU hCG, on the other hand control group received 0.5 ml of normal saline 2\u20133 min before IUI in single sitting. The main outcomes were CPR, miscarriage rate, and ongoing pregnancy rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis:<\/jats:title>\n                    <jats:p>It was performed using statistical software version SPSS 17.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patient's demographic and baseline characteristics were comparable in both the groups. CPR in experimental group was significantly high compared to control group (26% vs. 9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). Ongoing pregnancy rate was also significantly higher in experimental group (23%) compared to control group (7%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). No significant difference in miscarriage rate was seen between the two groups. No cases of ectopic pregnancy, ovarian hyperstimulation syndrome, or multiple pregnancy were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Intrauterine hCG administration is a simple procedure that can be used to improve pregnancy outcome in IUI cycles.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_196_20","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T10:58:50Z","timestamp":1624791530000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Intrauterine Administration of Human Chorionic Gonadotropin before Intrauterine Insemination in Infertile Women"],"prefix":"10.4103","volume":"14","author":[{"given":"Leena","family":"Wadhwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240905","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.fertnstert.2011.09.044","article-title":"Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization\/intracytoplasmic sperm injection: A prospective randomized study","volume":"96","author":"Mansour","year":"2011","journal-title":"Fertil Steril"},{"key":"R2-9-20240905","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11154-011-9193-1","article-title":"Extragonadal actions of chorionic gonadotropin","volume":"12","author":"Banerjee","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"R3-9-20240905","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7827-8-102","article-title":"Biological functions of hCG and hCG-related molecules","volume":"8","author":"Cole","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"R4-9-20240905","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7827-10-24","article-title":"HCG, the wonder of today's science","volume":"10","author":"Cole","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"R5-9-20240905","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/humupd\/dmm011","article-title":"Evian Annual Reproduction (EVAR) Workshop Group. The role of the endometrium and embryo in human implantation","volume":"13","author":"Diedrich","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R6-9-20240905","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1933719113477486","article-title":"Complement C3 and decay-accelerating factor expression levels are modulated by human chorionic gonadotropin in endometrial compartments during the implantation window","volume":"20","author":"Palomino","year":"2013","journal-title":"Reprod Sci"},{"key":"R7-9-20240905","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1177\/1933719114522553","article-title":"Human chorionic gonadotropin enhances trophoblast-epithelial interaction in an in vitro model of human implantation","volume":"21","author":"Racicot","year":"2014","journal-title":"Reprod Sci"},{"key":"R8-9-20240905","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/humupd\/4.5.532","article-title":"Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis","volume":"4","author":"Licht","year":"1998","journal-title":"Hum Reprod Update"},{"key":"R9-9-20240905","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2006.09.016","article-title":"Is human chorionic gonadotropin directly involved in the regulation of human implantation?","volume":"269","author":"Licht","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"R11-9-20240905","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1095\/biolreprod.112.100370","article-title":"Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: A new possible mechanism underlying embryo implantation","volume":"87","author":"Bourdiec","year":"2012","journal-title":"Biol Reprod"},{"key":"R12-9-20240905","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/oxfordjournals.humrep.a136021","article-title":"Role of growth factors during peri-implantation development","volume":"10","author":"Harvey","year":"1995","journal-title":"Hum Reprod"},{"key":"R13-9-20240905","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.171.5.2305","article-title":"Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system","volume":"171","author":"Kayisli","year":"2003","journal-title":"J Immunol"},{"key":"R14-9-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-12-9","article-title":"Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: A prospective study","volume":"12","author":"Santiba\u00f1ez","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"R15-9-20240905","first-page":"1","article-title":"Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization\/intracytoplasmic sperm injection: A randomized clinical tria","volume":"12","author":"Zarei","year":"2014","journal-title":"Iran J Reprod Med"},{"key":"R16-9-20240905","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.fertnstert.2014.08.006","article-title":"Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: A randomized, double-blind, placebo-controlled trial","volume":"102","author":"Hong","year":"2014","journal-title":"Fertil Steril"},{"key":"R17-9-20240905","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-015-0069-1","article-title":"Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: A randomised prospective study","volume":"13","author":"Wirleitner","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"R18-9-20240905","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/humrep\/dew236","article-title":"Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: A randomized controlled trial","volume":"31","author":"Navali","year":"2016","journal-title":"Hum Reprod"},{"key":"R19-9-20240905","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/humrep\/dew080","article-title":"Intrauterine human chorionic gonadotropin infusion in oocyte donors promotes endometrial synchrony and induction of early decidual markers for stromal survival: A randomized clinical trial","volume":"31","author":"Strug","year":"2016","journal-title":"Hum Reprod"},{"key":"R20-9-20240905","first-page":"CD011537","article-title":"Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction","volume":"10","author":"Craciunas","year":"2018","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_196_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:20:30Z","timestamp":1787844030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_196_20"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_196_20","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}